| Position | Action |
|---|---|
| Close below $153.75 (10 EMA) on rising volume | 25-30% trim signal (not full exit) |
| Decisive close below $146.38 (50 SMA) on heavy volume | Hard mental stop — invalidate constructive setup |
Q2 2026 delivered Exxon's best quarterly profit in four years, confirming the bull case as the structural refining margin boom and forward earnings growth far outweigh backward-looking Q1 deterioration; the technical setup with price above all major moving averages and healthy RSI reset supports a continued uptrend with pullback entries.
| Indicator | Value | Signal |
|---|---|---|
| close_200_sma | 138.92 | bullish |
| close_50_sma | 146.38 | bullish |
| close_10_ema | 153.75 | bullish |
| rsi | 59.39 | bullish |
| macd | 2.86 | bullish |
| macd_signal | 2.91 | neutral |
| macd_histogram | -0.05 | bearish |
| atr | 3.82 | — |
Support: 138.92 · 146.38 · 147.24 · 150.97 | Resistance: 155 · 156.94 · 170.84
XOM exhibits a bullish trend stack with price (154.84) above all three moving averages — 10 EMA at 153.75, 50 SMA at 146.38 (rising since Jul 17), and 200 SMA at 138.92 (rising from 131.65 in June). RSI at 59.39 is in a constructive zone (55–65), indicating bullish momentum without overbought conditions, while MACD crossed above its signal line on Jul 22 and remains above zero at 2.86, though the histogram has turned marginally negative (-0.05) — signaling a short-term cool-down that warrants monitoring. Volatility has compressed, with ATR declining from 4.45 (Jun 15) to 3.82, and today's range of 3.01 fell below ATR, suggesting a coiled-spring setup. Key resistance sits at 156.94 (Jul 23–24 swing high) and 170.84 (March peak), while support aligns at 150.97 (1× ATR stop), 147.24 (2× ATR stop aligned with 50 SMA), and the 200 SMA at 138.92. Hold existing trend-aligned positions; await pullback entries to the 10 EMA or 50 SMA, or a decisive close above 156.94 for breakout confirmation.
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
Maintain XOM at current position size — do not initiate new buying and do not trim aggressively
Hold with refined discipline, not passive drift.
Record refining margins from Middle East supply disruptions provide structural, underappreciated tailwind
↩ rebuts: “Bear's assumption that oil price weakness collapses refining margins”
· concedes: Lower crude prices could pressure upstream realizations, though the bull argues this is offset by wider crack spreads from tight product markets; Q1 2026 deterioration was real and concerning at the time; MACD histogram printed slightly negative (-0.05), representing minor momentum cooling; Political rhetoric creates headline risk even if policy translation is unlikely
XOM is priced for a continuation of the best-case macro setup while the underlying business shows clear deterioration, the balance sheet is being stretched to fund capital returns, and the macro environment is actively shifting against the bull case.
· concedes: Q2 delivered genuinely strong results; Long-term trend (10 EMA, 50 SMA, 200 SMA) remains intact; XOM has defensive characteristics with 0.17 beta; Forward P/E of 14.66x vs TTM of 26.07x appears reasonable on surface; XOM's size and dividend stability are genuine structural advantages; Political risk could ultimately not materialize as policy
→ vs conservative: Claims rally has priced in good news—refutes with 12% pullback from March high and coiled-spring volatility compression
→ vs conservative: Calls MACD histogram at minus 0.05 'five basis points' noise, not bearish cross
→ vs neutral: Dismisses Q1 weakness as 'stale news' and 'analytical malpractice' to extrapolate when Q2 was best profit in four years
→ vs conservative: Calls treating working capital drawdown 'like a credit crisis' wrong—TTM FCF of 20.67B funds dividends and buybacks
→ vs conservative: Reframes Polymarket 60% Hormuz normalization as 40% tailwind persistence plus 88% probability through August
Market Capitalization
$641.80B
Share Price (implied)
~$154.85
52-Week High
$176.41
52-Week Low
$105.53
50-Day Moving Average
$146.37
200-Day Moving Average
$139.37
Beta
0.173
Dividend Yield
2.66%
P/E Ratio (TTM)
26.07
Forward P/E
14.66
Forward EPS
$10.56
PEG Ratio
1.32
P/B Ratio
2.45
Book Value/Share
$63.08
Revenue (TTM)
$361.06B
Gross Profit (TTM)
$107.48B
EBITDA (TTM)
$67.94B
Operating Margin
15.86%
Net Income (TTM)
$32.76B
Net Profit Margin
9.07%
Return on Equity (ROE)
12.58%
Return on Assets (ROA)
5.52%
Q1 2026 Revenue
$83.16B
Q1 2026 Cost of Revenue
$69.27B
Q1 2026 Gross Profit
$13.89B
Q1 2026 Operating Income
$5.35B
Q1 2026 EBITDA
$14.03B
Q1 2026 Pretax Income
$6.97B
Q1 2026 Net Income
$4.18B
Q1 2026 Diluted EPS
$1.00
Sequential Quarterly Net Income Trend
$7.71B → $6.50B → $4.18B
Q1 2026 Total Assets
$464.41B
Q1 2026 Stockholders' Equity
$254.38B
Q1 2026 Total Debt
$47.66B
Q1 2026 Cash & Equivalents
$8.44B
Q1 2026 Net Debt
$39.23B
Q1 2026 Current Ratio
1.135
Q1 2026 Working Capital
$3.41B
Q1 2026 Debt-to-Equity
15.92
Q1 2026 Operating Cash Flow
$8.71B
Q1 2026 CapEx
$6.47B
Q1 2026 Free Cash Flow
$2.24B
TTM Free Cash Flow
$20.67B
Q1 2026 Dividends Paid
$4.33B
Q1 2026 Buybacks
$4.87B
Q1 2026 Total Shareholder Returns
$9.20B
FCF to Shareholder Returns Shortfall
$7B
Diluted Share Count Reduction
~4%
Total Shareholder Yield
~5.5-6%
vs. 50-Day MA
+5.8%
vs. 200-Day MA
+11.1%
Distance from 52-Week High
-12.2%
Strengths
Concerns
ExxonMobil presents a conflicted fundamental picture with significant deterioration in its most recent quarter. Q1 2026 earnings collapsed 45.8% YoY to $4.18B despite modest revenue growth, as cost of revenue surged 10.7% compressing gross margins to 16.7%. The balance sheet shows alarming deterioration with net debt nearly doubling (+91% to $39.23B), cash halved, and working capital down 80%. Free cash flow collapsed to just $2.24B while the company returns $9.2B quarterly to shareholders—a $7B shortfall funded by new debt issuance, a classic late-cycle capital allocation pattern. The forward P/E of 14.66x implies ~78% earnings recovery vs TTM, which the company needs to justify current valuations given the elevated 26.07x TTM multiple. Long-term income investors may find the 2.66% dividend attractive, but momentum traders should await confirmed margin recovery before acting.